Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commissioner Update: Announcement Timing Provides Clues

This article was originally published in The Pink Sheet Daily

Executive Summary

White House says decision will be unveiled this week. The timing offers clues to who may have made the final cut.

You may also be interested in...



OMB health desk appointment

Keith Fontenot has been recruited from the Congressional Budget Office to head the health desk at the Office of Management and Budget. At OMB he will join his former boss, Peter Orszag, OMB's new director. Fontenot previously served as a top aide for health care budgeting at CBO and is a 26-year veteran of budget analysis in health and human service areas. His new role puts him in a prominent position to monitor the purse strings of government activities, including entitlement programs run by CMS, research funding by the National Institutes of Health and drug regulation by FDA

Flaws Of ‘Virtual’ Advisory Committees Highlighted At Aducanumab Panel

The intensely negative advisory committee for Biogen’s proposed Alzheimer’s therapy was a shocker. Would it have happened if US FDA had been able to convene an in-person event instead of a ‘virtual’ one?

The Greatest FDA Advisory Committees, Part III: The Power of The Patients

With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years.

Topics

UsernamePublicRestriction

Register

LL1126230

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel